Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 147 entries
View as:

Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT01722513 Org: User:
Start: 11/30/12 End: 02/28/14 Due: 02/28/15

The Dynamic Fluctuation of Donor Microbiota Affects the Prognosis of Fecal Microbiota Transplantation for C. Difficile Infection

Phase: N/A Priority: Normal
NCT ID: NCT05703477 Org: User:
Start: 01/01/20 End: 08/30/22 Due: 08/30/23

Treating PCOS With Digital Intervention vs. Metformin

Phase: N/A Priority: Normal
NCT ID: NCT05386706 Org: User:
Start: 06/21/22 End: 09/01/23 Due: 09/01/24

Clinical Study of Fecal Microbiota Transplantation in the Treatment of Antibiotic-associated Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT05990972 Org: User:
Start: 07/20/20 End: 07/20/23 Due: 07/20/24

Efficacy and Safety of Paclitaxel-eluting Balloons for Below the Knee Peripheral Arterial Disease

Phase: N/A Priority: Normal
NCT ID: NCT02772224 Org: User:
Start: 06/30/16 End: 09/30/17 Due: 09/30/18

Acupoint Therapy Device for Dry Eye

Phase: N/A Priority: Normal
NCT ID: NCT06720428 Org: User:
Start: 01/01/21 End: 05/31/24 Due: 05/31/25

Prognosis in the Elderly Chinese: the Northern Shanghai Study

Phase: N/A Priority: Normal
NCT ID: NCT02368938 Org: User:
Start: 08/31/14 End: - Due: -

Sevoflurane, Propofol and Desflurane on POD/POCD

Phase: N/A Priority: Normal
NCT ID: NCT03326960 Org: User:
Start: 01/01/16 End: 06/30/21 Due: 06/30/22

Intervention Study on Digital Health Management

Phase: N/A Priority: Normal
NCT ID: NCT06949306 Org: User:
Start: 07/01/25 End: 12/31/30 Due: 12/31/31

Effect of Meal Replacement Beverage(Glucerna) on Body Composition,Lipid Metabolism and Blood Pressure

Phase: N/A Priority: Normal
NCT ID: NCT02118389 Org: User:
Start: 10/31/13 End: 12/31/13 Due: 12/31/14

GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS)

Phase: N/A Priority: Normal
NCT ID: NCT04876027 Org: User:
Start: 05/15/21 End: 05/10/22 Due: 05/10/23

Left Atrial Appendage Occlusion in Patients With Non-valvular Atrial Fibrillation From Shanghai

Phase: N/A Priority: Normal
NCT ID: NCT03987945 Org: User:
Start: 05/01/19 End: 06/30/20 Due: 06/30/21

Orlistat Reduces Uric Acid in Overweight/Obese Patients With Hyperuricemia

Phase: N/A Priority: Normal
NCT ID: NCT05496075 Org: User:
Start: 08/26/22 End: 12/01/23 Due: 12/01/24

PCOS Patients' Immune Alterations

Phase: N/A Priority: Normal
NCT ID: NCT06325969 Org: User:
Start: 11/03/23 End: 07/15/25 Due: 07/15/26

The Role of L-arginine in Polycystic Ovary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06728644 Org: User:
Start: 07/14/24 End: 08/20/25 Due: 08/20/26

Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT05557240 Org: User:
Start: 09/13/22 End: 08/12/25 Due: 08/12/26

Impact of Probiotics Supplement on the Gut Microbiota in Caesarean-born Infants

Phase: N/A Priority: Normal
NCT ID: NCT05086458 Org: User:
Start: 08/17/21 End: 10/17/21 Due: 10/17/22

The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT02338128 Org: User:
Start: 01/31/15 End: 01/31/18 Due: 01/31/19

Ankle Brachial Index Combined With Serum Uric Acid Levels Improve Prediction All Cause Mortality and Cardiovascular Mortality in the Elderly Chinese Population

Phase: N/A Priority: Normal
NCT ID: NCT03616418 Org: User:
Start: 01/01/17 End: 08/01/21 Due: 08/01/22

C-reactive Protein，Homocysteine，Postoperative Delirium

Phase: N/A Priority: Normal
NCT ID: NCT05164965 Org: User:
Start: 01/10/22 End: 12/30/23 Due: 12/30/24

Sequential Treatment of Extra-Corporeal Shock Wave Combined With aUtologous Bone marRow Mesenchymal Stem Cells on Patients With ischEmic Heart Disease : the S-CURE Study

Phase: N/A Priority: Normal
NCT ID: NCT03397095 Org: User:
Start: 04/03/18 End: 04/01/22 Due: 04/01/23

Evaluation of Microcirculation of Peripheral Vascular Disease in Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03528811 Org: User:
Start: 08/01/16 End: 07/31/18 Due: 07/31/19

Safety and Efficacy Assessments of Osalmid in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03670173 Org: User:
Start: 10/01/18 End: 05/18/21 Due: 05/18/22

Early Prevention Strategies of Severe Proliferative Vitreoretinopathy Base on Precision Diagnosis of Single Cell Sequencingvitreoretinopathy

Phase: N/A Priority: Normal
NCT ID: NCT04520789 Org: User:
Start: 09/01/20 End: 12/31/22 Due: 12/31/23

Treatment of Perioperative Neurocognitive Disorders With Olfactory Enrichment

Phase: N/A Priority: Normal
NCT ID: NCT06488807 Org: User:
Start: 04/07/25 End: 12/31/28 Due: 12/31/29